comparemela.com

Latest Breaking News On - India life sciences fund - Page 13 : comparemela.com

MediBuddy raises $40 million in Series B funding

MediBuddy raises $40 million in Series B funding The companies raised money for funding expansion plans, retiring debt, supporting working capital requirements and other general corporate purposes. 1 min read Share Via BENGALURU : Digital healthcare platform MediBuddy on Tuesday said that it has closed its Series B funding at $40 million led by India Life Sciences Fund III, LLC, along with participation from other investors. TRENDING STORIESSee All 1 min read . 22 Mar 2021 Mumbai sees over 3,000 new covid cases for second day in a row, 316 buildings sealed 1 min read 2 min read 2 min read . 12:29 AM IST The company had earlier raised $20 million in June 2020 as part of its ongoing Series B round, while announcing its merger with online doctor consultation startup DocsApp. The company now said that moving forward both companies will be operating under a single brand name - MediBuddy.

Healthcare platform MediBuddy raises $40 m in Series B funding

Healthcare platform MediBuddy raises $40 m in Series B funding February 02, 2021 MediBuddy co-founders Satish Kannan (left) and Enbasekar× MediBuddy, a digital healthcare platform, has announced the closure of its $40 million Series B round on Tuesday. The firm had announced an initial funding of $20 million (₹150 crore) in June 2020 under this round, led by India Life Sciences Fund III, LLC with participation from other investors. The Series B round attracted new investments from India Life Sciences Fund III, TEAMFund LP, JAFCO Asia Fund, FinSight Ventures, ALES Global Japan and Beyond Next Ventures. Existing investors including Bessemer Venture Partners, Milliways Ventures and Rebright Partners also participated in this round.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.